gemigliptin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
dipeptidyl aminopeptidase-IV inhibitors 4833 911637-19-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • gemigliptin
  • zemiglo
  • LC15-0444
Dipeptidyl Peptidase IV Inhibitors; orally active small molecule for the treatment of type II diabetes
  • Molecular weight: 489.37
  • Formula: C18H19F8N5O2
  • CLOGP: 0.87
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 1
  • TPSA: 92.42
  • ALOGS: -3.77
  • ROTB: 6

Drug dosage:

DoseUnitRoute
50 mg O

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

gemigliptin